Pharma news
Americas
Jason Rutt considers the impact AstraZeneca’s recent US pay-for-delay case will have on the industry. 3 November 2014
Pharma
The current outbreak of Ebola has devastated communities in West Africa. It has also thrown a light on the complex web of IP rights surrounding the possible treatments for this serious and usually fatal virus, as LSIPR discovered. 3 November 2014
Americas
AstraZeneca has had a tough few years, with a clutch of patent expiries one of the most serious of its problems. So where does it go from here? To find out, LSIPR spoke to the Anglo-Swedish pharmaceutical company’s vice president of business development about the role IP is playing in its plans for future success. 3 November 2014
Asia-Pacific
Brand owners may use a multitude of approaches to crack down effectively on fake drugs. Andy Leck and Ren Jun Lim discuss the challenges of anti-counterfeiting efforts in Singapore. 3 November 2014
Americas
A US court has ruled that pharmaceutical company Mylan infringed a patent owned by The Medicines Company covering a product used to inhibit blood clots. 29 October 2014
Pharma
Pharmaceutical company Bristol-Myers Squibb has agreed a deal that gives it the option of acquiring drug maker F-star Alpha and one of its breast and gastric cancer treatments. 28 October 2014
Americas
Pharmaceutical company AstraZeneca has filed a patent infringement lawsuit against drug maker Pharmadax after it applied to market a generic version of a schizophrenia and bipolar disorder treatment. 27 October 2014
Pharma
Pharmaceutical company Roche has announced it will be building a new multi-billion research and development centre. 22 October 2014
Americas
The US Court of Appeals for the Federal Circuit has limited a judge’s power to enforce local rules in a patent dispute involving pharmaceutical company Pfizer and an anti-cancer treatment company. 21 October 2014
Pharma
Pharmaceutical and biologics company AstraZeneca and the University of Cambridge have teamed up as part of a programme aimed at increasing life science-related research and teaching. 20 October 2014